
Innovative vascular health company recognized for commitment to growth, innovation, and community impact in North Texas
DALLAS, TX — September 9, 2025 — Koya Medical (“Koya”), a global leader in vascular health innovation, is proud to announce it has been honored with the Building Tomorrow Together Award by the Dallas Regional Chamber (DRC).
The award will be presented at the inaugural Tomorrow Summit at Hall Park Hotel in Frisco, where more than 300 of the region’s top business leaders will gather to explore the future of economic growth and innovation across North Texas.
The Building Tomorrow Together Award celebrates organizations driving growth, innovation, and opportunity in the Dallas region. Earlier this year, Koya Medical opened its new headquarters in Dallas, reinforcing its commitment to the community and advancing its mission to transform vascular care.
“We are honored to receive the Dallas Regional Chamber’s Building Tomorrow Together Award,” said Andy Doraiswamy, Founder & CEO of Koya Medical. “Opening our Dallas headquarters has been a pivotal step in accelerating innovation and expanding access to care for people living with venous and lymphatic conditions. We are inspired by this community’s talent, creativity, and collaborative spirit—and we’re excited to grow our future here."
About Koya Medical
Founded in 2018 and now headquartered in Dallas, Koya Medical is redefining vascular health with patient-centered solutions designed to support care from clinic to home. Inspired by a personal journey with vascular disease, Koya’s mission is to close treatment gaps and improve lives—starting with its FDA-cleared Dayspring system and advancing through a growing innovation pipeline.
Why Vascular Health Matters
More than 35 million Americans live with venous and lymphatic diseases—serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health—highlighting the urgent need for modern, evidence-based care.
Learn more at www.koyamedical.com and follow Koya on LinkedIn.